Latest Australian Government Funding News

Page 1 of 1
Firebird Metals has secured a key patent for its energy-efficient kiln and announced plans for an Australian Demonstration Plant to commercialise its battery materials technology.
Maxwell Dee
Maxwell Dee
28 Nov 2025
Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.
Maxwell Dee
Maxwell Dee
25 Nov 2025
Power Minerals has partnered with Australian tech firm Gega Elements to develop a gallium extraction process from its Santa Anna Project in Brazil, aiming to establish a vertically integrated supply chain amid rising global demand and supply risks.
Maxwell Dee
Maxwell Dee
18 Nov 2025
Lindian Resources has approved the Final Investment Decision for its Kangankunde Rare Earths Project, securing full funding and a strategic partnership with Iluka Resources. The company is raising A$91.5 million via institutional placement to advance development and expansion plans.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Renascor Resources has achieved provisional development approval for its commercial-scale Battery Anode Material manufacturing facility, alongside significant progress in graphite production and exploration activities. The company maintains a robust cash position of A$105 million as it advances its vertically integrated graphite project.
Maxwell Dee
Maxwell Dee
31 July 2025
Renascor Resources has successfully produced high-grade graphite concentrate from its Siviour deposit, exceeding feasibility study benchmarks and setting the stage for its Australian Government-backed PSG demonstration plant. This milestone comes as US tariffs on Chinese anode materials surge, spotlighting Renascor’s strategic role in diversifying supply.
Maxwell Dee
Maxwell Dee
25 July 2025
Argenica Therapeutics has dosed the final patient in its Phase 2 trial for ARG-007 in acute ischaemic stroke, with topline results expected in Q3 2025. Meanwhile, the FDA has placed a clinical hold on its US trial application, introducing uncertainty for US development.
Ada Torres
Ada Torres
23 July 2025
Sumitomo Corporation's subsidiary has gained crucial Foreign Investment Review Board approval to invest in Tivan Limited's Speewah Fluorite Project, paving the way for a significant joint venture.
Maxwell Dee
Maxwell Dee
18 June 2025
Biome Australia has partnered with the Food and Beverage Accelerator (FaBA) to jointly develop its promising BMB18 probiotic strain, leveraging $50 million in Australian government funding while retaining full IP ownership.
Victor Sage
Victor Sage
5 Feb 2025